In both androgen-sensitive and castration-resistant AR-driven prostate cancers, AR signaling upregulates the expression of Drp-1, which supports cancer cell survival under various metabolic stresses—such as hypoxia and oxidative stress—thereby enhancing cell survival and proliferation. The gene discussed is DNM1L; the disease is prostate carcinoma.